Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Commonalities in epileptogenic processes from different acute brain insults: Do they translate?
Pavel Klein, Raymond Dingledine, Eleonora Aronica, et al.
Epilepsia (2017) Vol. 59, Iss. 1, pp. 37-66
Open Access | Times Cited: 248

Showing 1-25 of 248 citing articles:

Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy
Annamaria Vezzani, Silvia Balosso, Teresa Ravizza
Nature Reviews Neurology (2019) Vol. 15, Iss. 8, pp. 459-472
Closed Access | Times Cited: 659
Structural, Molecular, and Functional Alterations of the Blood-Brain Barrier during Epileptogenesis and Epilepsy: A Cause, Consequence, or Both?
Wolfgang Löscher, Alon Friedman
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 591-591
Open Access | Times Cited: 185
Dual roles of astrocytes in plasticity and reconstruction after traumatic brain injury
Yunxiang Zhou, Anwen Shao, Yihan Yao, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 172
Biomarkers in traumatic brain injury (TBI): a review
Aaron Dadas, Jolewis Washington, Ramon Diaz‐Arrastia, et al.
Neuropsychiatric Disease and Treatment (2018) Vol. Volume 14, pp. 2989-3000
Open Access | Times Cited: 167
Inflammation and reactive oxygen species as disease modifiers in epilepsy
Gaetano Terrone, Silvia Balosso, Alberto Pauletti, et al.
Neuropharmacology (2019) Vol. 167, pp. 107742-107742
Closed Access | Times Cited: 166
The metabolic basis of epilepsy
Jong M. Rho, Detlev Boison
Nature Reviews Neurology (2022) Vol. 18, Iss. 6, pp. 333-347
Closed Access | Times Cited: 149
Seizures and Epilepsy After Stroke: Epidemiology, Biomarkers and Management
Marian Galovic, Carolina Ferreira‐Atuesta, Laura Abraira, et al.
Drugs & Aging (2021) Vol. 38, Iss. 4, pp. 285-299
Open Access | Times Cited: 121
Astrocytes in the initiation and progression of epilepsy
Annamaria Vezzani, Teresa Ravizza, Peter Bedner, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 12, pp. 707-722
Open Access | Times Cited: 104
Neuroinflammatory mediators in acquired epilepsy: an update
Yu Chen, Marwa M. Nagib, Nelufar Yasmen, et al.
Inflammation Research (2023) Vol. 72, Iss. 4, pp. 683-701
Open Access | Times Cited: 59
Neuroinflammation microenvironment sharpens seizure circuit
Benjamín Villasana‐Salazar, Annamaria Vezzani
Neurobiology of Disease (2023) Vol. 178, pp. 106027-106027
Open Access | Times Cited: 43
mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
Teresa Ravizza, Mirte Scheper, Rossella Di Sapia, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 5, pp. 334-350
Closed Access | Times Cited: 28
New epilepsy therapies in development
Pavel Klein, Rafal M. Kaminski, Matthias J. Koepp, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 682-708
Closed Access | Times Cited: 28
Epilepsy biomarkers – Toward etiology and pathology specificity
Asla Pitkänen, Xavier Ekolle Ndode‐Ekane, Niina Lapinlampi, et al.
Neurobiology of Disease (2018) Vol. 123, pp. 42-58
Open Access | Times Cited: 152
Reactive Glia Inflammatory Signaling Pathways and Epilepsy
Pascual Sanz, María Adelaida García-Gimeno
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4096-4096
Open Access | Times Cited: 133
The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments
Wolfgang Löscher
Neuropharmacology (2019) Vol. 167, pp. 107605-107605
Closed Access | Times Cited: 124
Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy
Yam Nath Paudel, Mohd. Farooq Shaikh, Sadia Shah, et al.
European Journal of Pharmacology (2018) Vol. 837, pp. 145-155
Closed Access | Times Cited: 119
Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability
Balázs Pál
Cellular and Molecular Life Sciences (2018) Vol. 75, Iss. 16, pp. 2917-2949
Closed Access | Times Cited: 113
Dual-center, dual-platform microRNA profiling identifies potential plasma biomarkers of adult temporal lobe epilepsy
Rana Raoof, Sebastian Bauer, Hany El‐Naggar, et al.
EBioMedicine (2018) Vol. 38, pp. 127-141
Open Access | Times Cited: 99
The role of adenosine in epilepsy
Landen Weltha, Jesica Reemmer, Detlev Boison
Brain Research Bulletin (2018) Vol. 151, pp. 46-54
Open Access | Times Cited: 99
Viral infections and their relationship to neurological disorders
Jéssica Wouk, Daniele Zendrini Rechenchoski, Bianca Cerqueira Dias Rodrigues, et al.
Archives of Virology (2021) Vol. 166, Iss. 3, pp. 733-753
Open Access | Times Cited: 96
n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis
Federica Frigerio, Giulia Pasqualini, Ilaria Craparotta, et al.
Brain (2018)
Open Access | Times Cited: 88
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
Pavel Klein, Alon Friedman, Mustafa Q. Hameed, et al.
Epilepsia (2020) Vol. 61, Iss. 3, pp. 359-386
Open Access | Times Cited: 86
Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma
Paolo Strati, Loretta J. Nastoupil, Jason R. Westin, et al.
Blood Advances (2020) Vol. 4, Iss. 16, pp. 3943-3951
Open Access | Times Cited: 86
Pharmacological targeting of brain inflammation in epilepsy: Therapeutic perspectives from experimental and clinical studies
Teresa Ravizza, Annamaria Vezzani
Epilepsia Open (2018) Vol. 3, Iss. S2, pp. 133-142
Open Access | Times Cited: 84
Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
Wolfgang Löscher
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 84
Page 1 - Next Page

Scroll to top